Proteoglycans production by aortic vascular smooth muscle cells from hypertensive rats

Biocell

Volumn 27, Issue 2, 2003, Pages 189-196

  Risler, Norma ^a,b   Castro, Claudia ^a   Cruzado, Montserrat ^a   González, Susana ^a   Miatello, Roberto ^a  

^a UNIVERSIDAD NACIONAL DE CUYO   (Argentina)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

Extracellular matrix proteoglycans; Hypertension; Spontaneously hypertensive rats; Vascular smooth muscle cells

Indexed keywords

DISACCHARIDE; DNA; GLUCOSAMINE; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; PROTEOGLYCAN; SODIUM SULFATE; SULFUR 35; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; AORTA; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL COMPLIANCE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; EXTRACELLULAR MATRIX; FETAL CALF SERUM; HYPERTENSION; MALE; NONHUMAN; PROTEOGLYCAN SYNTHESIS; RAT; SULFATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; ARTERIOSCLEROSIS; CELL DIVISION; CELLS, CULTURED; EXTRACELLULAR MATRIX; GLUCOSAMINE; HYPERTENSION; HYPERTROPHY; MALE; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; PROTEOGLYCANS; RATS; RATS, INBRED SHR; SULFATES; SULFUR RADIOISOTOPES;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0041689594     PISSN: 03279545     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Archer SL (1996). Diversity of phenotype and function of vascular smooth muscle cells. J Lab Clin Med. 127: 524-529.
2. Benetos A, Kaurent S, Asmar RG, Lacolley P (1997). Large artery stiffness in hypertension. J Hypertens. 15 (suppl2): S89-S97.
3. Berk BC (2001). Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev. 81: 999-1030.
4. Carey D (1991). Control of growth and differentiation of vascular cells by extracellular matrix proteins. Ann Rev Physiol. 53: 161-177.
5. Castro CM, Cruzado MC, Miatello RM, Risler NR (1999). Proteoglycan production by vascular smooth muscle cells from resistance arteries of hypertensive rats. Hypertension. 34 (part 2): 893-896.
6. Chait A, Wight TN (2000). Interaction of native and modified low-density lipoproteins with extracellular matrix. Curr Opin Lipid. 11: 457-463.
7. Chamiot-Clerc P, Renaud JF, Blacher J, Legrand M, Samuel JL, Levy BI, Sassard J, Safar ME (1999). Collagen I and III and mechanical properties of conduit arteries in rats with genetic hypertension. J Vasc Res. 36: 139-146.
8. Chamley-Campbell JH, Campbell JR, Ross R (1981). Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens. J Cell Biol. 89: 379-383.
9. Cruzado M, Risler N, Castro C, Ortiz A, Rüttler M (1998). Proliferative effect of insulin on cultured smooth muscle cells from mesenteric resistance vessels. Am J Hypertens. 11: 54-58.
10. Daemen MJAP, De Mey JGR (1995). Regional heterogeneity of arterial structural changes. Hypertension. 25 (part I): 464-473.
11. Diez J, Fortuno MA, Zalba G, Etayo JC, Ravassa S, Beaumont J (1998). Altered regulation of smooth muscle cell proliferation and apoptosis in small arteries of spontaneously hypertensive rats. Eur Heart J. 19 Suppl G: G29-33.
12. Dingemans KP, Teeling P, Lagendijk JH, Becker AE (2000). Extracellular matrix of the human aortic media: an ultrastructural histochemical and immunohistochemical study of the tochemical and immunohistochemical study of the adult aortic media. Anat Rec. 258: 1-14.
13. Dubey RK, Jackson EK, Rupprecht HD, Sterzel RB (1997). Factors controlling growth and matrix production in vascular smooth muscle and glomerular mesangial cells. Curr Opin Nephrol Hypertens. 6: 88-105.
14. Emoto N, Onose H, Yamada H, Minami S, Tsushima T, Wakabayashi I (1998). Growth factors increase pericellular proteoglycans independently of their mitogenic effects on AIO rat vascular smooth muscle cells. Int J Biochem. 30: 47-54.
15. Evanko SP, Johnson PY, Braun KR, Underhill CB, Dudhia J, Wight TN (2001). Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells. Arch Biochem Biophys. 394: 29-38.
16. Frid MG, Dempsey EC, Durmowicz AG, Stenmark KR (1997). Smooth muscle heterogeneity in pulmonary and systemic vessels. Importance in vascular disease. Arterioscler Thromb Vasc Biol. 17: 1203-1209.
17. Hadrava V, Tremblay J, Hamet P (1989). Abnormalities in growth characteristics of aortic smooth muscle cells in spontaneously hypertensive rats. Hypertension. 13: 589-597.
18. Hadrava V, Kruppa U, Russo RC, Lacourciere Y, Tremblay J, Hamt P (1991). Vascular smooth muscle cell proliferation and its therapeutic modulation in hypertension. Am Heart J. 122 (4 Pt2): 1198-11203.
19. Halayko AJ, Rector E, Stephens NL (1997). Characterization of molecular determinants of smooth muscle cell heterogeneity. Can J Physiol Pharmacol. 75: 917-929.
20. Hedin U, Roy J, Tran PK, Lundmark K, Rahman A (1999). Control of smooth muscle proliferation - the role of the basement membrane. Thromb Haemost. 82 Suppl 1: 23-26.
21. Hein M, Fisher J, Kim DK, Hein L, Pratt RE (1996). Vascular smooth muscle phenotype influences glycosaminoglycan composition and growth effects of extracellular matrix. J Vasc Res. 246: 279-292.
22. Hsieh CC, Lau Y (1998). Migration of vascular smooth muscle cells is enhanced in cultures derived from spontaneously hypertensive rat. Plugers Arch. 435(2): 286-292.
23. Intengan HD, Schiffrin EL (2001). Vascular remodeling in hypertension: roles of apoptosis, inflammation and fibrosis. Hypertension. 38 (Pt2): 581-587.
24. Intengan HD, Thibault G, Li JS, Schiffrin EL (1999). Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation. 100: 2267-2275.
25. Jacob MP, Badier-Commander C, Fontaine V, Benazzoug Y, Feldman L, Michel JB (2001). Extracellular matrix remodeling in the vascular wall. Pathol Biol. 49: 326-332.
26. Lee RT, Yamamoto C, Feng Y, Potter-Perigo S, Briggs WH, Landschulz KT, Turi TG, Thompson JF, Libby P, Wight TN (2001). Mechanical strain induces specific changes in the synthesis and organization of proteoglycans by vascular smooth muscle cells. J Biol Chem. 276: 13847-13851.
27. Lewis CD, Olson NE, Raines EW, Reidy MA, Jackson CL (2001). Modulation of smooth muscle proliferation in rat carotid artery by platelet-derived mediators and fibroblast growth factor-2. Platelets. 12: 352-358.
28. McLeod DC, Strauss BH, de Jong M, Escaned J, Umans V, van Suylen RJ, Verkerk A, de Feyter PJ, Serruys PW (1994). Proliferation and extracellular matrix synthesis of smooth muscle cells cultured from human coronary atherosclerotic and restenotic lesions. J Am Coll Cardiol. 23: 59-65.
29. Moran A, Brown DM, Kim Y, Klein DJ (1991). Effects of IGF-I and glucose on protein and proteoglycan synthesis by human fetal mesangial cells in culture. Diabetes 40: 1346-1354.
30. Nelson PR, Yamamura S, Kent KC (1997). Platelet-derived growth factor and extracellular matrix proteins provide a synergistic stimulus for human vascular smooth muscle migration. J Vasc Surg. 26: 104-112.
31. Pang SC (1989). Proliferation of aortic smooth muscle cells of genetically hypertensive and normotensive rats in culture. J Pathol. 158: 167-173.
32. Raines EW (2000). The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease. Int J Exp Pathol. 81: 173-182.
33. Raines EW, Koyama H, Carragher NO (2000). The extracellular matrix dynamically regulates smooth muscle cell responsiveness to PDGF. Ann New York Acad Sci. 902: 39-52.
34. Risler N, Castro C, Cruzado M, González S, Miatello R (2002). Early changes in proteoglycans production by resistance arteries smooth muscle cells of hypertensive rats. Am J Hypertens. 15: 416-421.
35. Rivard A, Andrés V (2000). Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases. Histol Histopathol. 15: 557-571.
36. Ruoshlati E, Yamaguchi Y (1991). Proteoglycans as modulators of growth factors activities. Cell. 64: 867-869.
37. Safar M, Frohlich E (1995). The arterial system in hypertension: a prospective view. Hypertension. 26: 10-14.
38. Schonherr E, Hausser HJ (2000). Extracellular matrix and cytokines: a functional unit. Dev Immunol. 7: 89-101.
39. Shanahan CM, Weissberg PL (1999). Smooth muscle cell phenotypes in atherosclerotic lesions. Curr Opin Lipidol. 10: 507-513.
40. Thiebot B, Bichoualne L, Langris M, Bonnamy PJ, Barbey P, Carreau S, Bocquet J (1997). IGF-I stimulates synthesis of undersulfated proteoglycans and of hyaluronic acid by peritubular cells from immature rat testis. Biochim Biophys Acta. 1358: 127-141.
41. Thogersen VB, Keickendorff L, Ledet T (1996). Effect of insulin and growth hormone on the synthesis of radiolabelled proteoglycans from cultured human arterial smooth muscle cells. Eur J Endocrinol. 134: 326-330.
42. Tuñón J, Ruiz-Ortega M, Egido J (2000). Regulation of matrix proteins and impact on vascular structure. Current Hypertension Reports. 2: 106-113.
43. Yanagishita M, Salustri A, Hascall V (1989). Specific activity of radiolabeled hexosamines in metabolic labeling experiments. Methods in Enzimology. 179: 435-445.
44. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM (1991). Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 64: 841-848.